Histone deacetylase 8 triggers the migration of triple negative breast cancer cells via regulation of YAP signals

被引:27
|
作者
An, Panpan [1 ]
Li, Jiexin [1 ]
Lu, Linlin [1 ]
Wu, Yingmin [1 ]
Ling, Yuyi [1 ]
Du, Jun [1 ]
Chen, Zhuojia [2 ]
Wang, Hongsheng [1 ]
机构
[1] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Microbial & Biochem Pharm, Guangdong Prov Key Lab New Drug Design & Evaluat, Guangzhou 510006, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
TNBC; Migration; HDAC8; YAP; TRANSCRIPTION; HDAC8; PROTEIN;
D O I
10.1016/j.ejphar.2018.12.030
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Triple-negative breast cancer (TNBC) shows highly aggressive clinical behaviors and poor prognosis compared to other breast cancer subtypes. Histone deacetylases (HDACs) can regulate the progression of various cancers, but the role of HDAC8 in TNBC remains unexplored. Here, we found that HDAC8 enhanced the in vitro migration abilities of breast cancer cells. Targeted inhibition of HDAC8 via si-HDAC8 and its selective inhibitor PCI34051 could suppress the migration of cells. In TNBC cells, HDAC8 stabilized the expression and increased the nuclear localization of YAP, a major downstream effector of Hippo pathway. While silencing YAP could attenuate HDAC8 triggered migration of TNBC cells. Mechanistically, HDAC8 suppressed the phosphorylation of YAP(ser127), which was related to its cytoplasmic sequestration degradation. Our data revealed that HDAC8 could trigger the migration of TNBC cells via regulation of Hippo-YAP signals, suggesting that HDAC8 might be a potential target for TNBC therapy.
引用
收藏
页码:16 / 23
页数:8
相关论文
共 50 条
  • [31] The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor α-negative breast cancer cells to tamoxifen
    Eun Ryoung Jang
    Soo-Jeong Lim
    Eun Sook Lee
    Gajin Jeong
    Tae-You Kim
    Yung-Jue Bang
    Jong-Soo Lee
    Oncogene, 2004, 23 : 1724 - 1736
  • [32] Histone deacetylase (HDAC) inhibitors exhibit antitumor activity in triple negative breast cancer via suppression of HER3 triggered signaling
    Tan, Congcong
    Lyu, Hui
    Ruan, Sanbao
    Liu, Bolin
    CANCER RESEARCH, 2022, 82 (12)
  • [33] The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor α-negative breast cancer cells to tamoxifen
    Jang, ER
    Lim, SJ
    Lee, ES
    Jeong, G
    Kim, TY
    Bang, YJ
    Lee, JS
    ONCOGENE, 2004, 23 (09) : 1724 - 1736
  • [34] C/EBPβ isoform-specific regulation of migration and invasion in triple-negative breast cancer cells
    Britt A. Sterken
    Tobias Ackermann
    Christine Müller
    Hidde R. Zuidhof
    Gertrud Kortman
    Alejandra Hernandez-Segura
    Mathilde Broekhuis
    Diana Spierings
    Victor Guryev
    Cornelis F. Calkhoven
    npj Breast Cancer, 8
  • [35] C/EBPβ isoform-specific regulation of migration and invasion in triple-negative breast cancer cells
    Sterken, Britt A.
    Ackermann, Tobias
    Mueller, Christine
    Zuidhof, Hidde R.
    Kortman, Gertrud
    Hernandez-Segura, Alejandra
    Broekhuis, Mathilde
    Spierings, Diana
    Guryev, Victor
    Calkhoven, Cornelis F.
    NPJ BREAST CANCER, 2022, 8 (01)
  • [36] Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity
    Cao, Dai
    Zhu, Guo-Yuan
    Lu, Yan
    Yang, Aiping
    Chen, Die
    Huang, Hui-Jie
    Peng, Shu-Xian
    Chen, Li-Wen
    Li, Ying-Wei
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 129
  • [37] miR-497 inhibits proliferation and invasion in triple-negative breast cancer cells via YAP1
    Li, Yuan
    Hua, Kaiyao
    Jin, Jiali
    Fang, Lin
    ONCOLOGY LETTERS, 2021, 22 (02)
  • [38] Efp promotes the growth and migration of triple-negative breast cancer cells
    Sato, Wataru
    Ikeda, Kazuhiro
    Gotoh, Noriko
    Horie, Kuniko
    Inoue, Satoshi
    CANCER SCIENCE, 2023, 114 : 1644 - 1644
  • [39] Angelicin inhibits the growth and migration of triple-negative breast cancer cells
    Chen, I-hsiao
    Chen, Chien-yu
    Lan, Yu-hsuan
    Chen, I-fen
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 36 (01) : 51 - 58
  • [40] Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells
    Ha, Kyungsoo
    Fiskus, Warren
    Choi, Dong Soon
    Bhaskara, Srividya
    Cerchietti, Leandro
    Devaraj, Santhana G. T.
    Shah, Bhavin
    Sharma, Sunil
    Chang, Jenny C.
    Melnick, Ari M.
    Hiebert, Scott
    Bhalla, Kapil N.
    ONCOTARGET, 2014, 5 (14) : 5637 - 5650